🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The immunogenicity of anti-tumor necrosis factor alpha (anti-TNF) therapy i...
Status
Terminated
Location
Indiana University Hospital
Start Date
2015-05
Trial ID
NCT02413047
Treatments Being Tested
In this research proposal, the investigators will focus on methods to optim...
Status
Unknown
Location
Montreal General Hospital
Start Date
2014-11-17
Trial ID
NCT02453607
Treatments Being Tested
Extracorporeal photopheresis (ECP) is an immunomodulatory therapy in which ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-07
Trial ID
NCT07619898
IDEA is a Phase IV, prospective, randomised, open-label, multicentre clinic...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-05-01
Trial ID
NCT07248644
Treatments Being Tested
This randomized, controlled study aims to evaluate the impact of therapeuti...
Status
Unknown
Location
Gastroenterology and Hepatology, Tokyo Medical and Dental UNIV
Start Date
2014-09
Trial ID
NCT02332356
Treatments Being Tested
Prospective, randomized, controlled clinical trial to determine the overall...
Status
Terminated
Location
Hospital Universitario y Politécnico La Fe
Start Date
2019-04-26
Trial ID
NCT03930459
Treatments Being Tested
Demyelinating Diseases of the Central Nervous System Registry for Patients ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2022-06-20
Trial ID
NCT05415579
Treatments Being Tested
Erdheim-Chester Diseases (ECD) is a very rare non-Langerhans cell histiocyt...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2014-11-01
Trial ID
NCT02281760
Treatments Being Tested
The objectives of this prospective non-interventional study are to characte...
Status
Recruiting
Location
Cahaba Dermatology & Skin Health Center- Site Number : 8400006
Start Date
2025-11-17
Trial ID
NCT07290803
The Torcetrapib project was terminated on December 2, 2006 due to safety fi...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2004-11
Trial ID
NCT00137462
Treatments Being Tested